NCCN Guidelines® Insights: Thyroid Carcinoma, version 1.2025: Featured Updates to the NCCN Guidelines Guidelines
| Authors: | Haddad, R. I.; Bischoff, L.; Applewhite, M.; Bernet, V.; Blomain, E.; Brito, M.; Busaidy, N. L.; Campbell, M.; DeLozier, O.; Duh, Q. Y.; Ehya, H.; Grady, E.; Guo, T.; Haymart, M.; Hunt, J. P.; Kandeel, F.; Kotwal, A.; Lamonica, D. M.; Lorch, J.; Mandel, S. J.; Markovina, S.; Mydlarz, W.; Nabell, L.; Raeburn, C. D.; Rezaee, R.; Ridge, J. A.; Ritter, H.; Roth, M. Y.; Salgado, S. A.; Scheri, R. P.; Shah, J. P.; Sipos, J. A.; Sippel, R.; Sturgeon, C.; Wirth, L. J.; Wong, R. J.; Worden, F.; Yeh, M. W.; Darlow, S.; Cassara, C. J.; Sliker, B. |
| Title: | NCCN Guidelines® Insights: Thyroid Carcinoma, version 1.2025: Featured Updates to the NCCN Guidelines |
| Abstract: | The NCCN Guidelines for Thyroid Carcinoma address the management of different types of thyroid carcinoma, including papillary, follicular, oncocytic, medullary, and anaplastic carcinoma. The NCCN Thyroid Carcinoma Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights focus on the panel's most recent recommendations regarding systemic therapies for thyroid carcinoma as well as the supporting clinical data. |
| Keywords: | practice guideline; pathology; oncology; diagnosis; medical oncology; thyroid neoplasms; thyroid tumor; therapy; humans; human |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 23 |
| Issue: | 7 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2025-07-01 |
| Language: | English |
| DOI: | 10.6004/jnccn.2025.0033 |
| PUBMED: | 40639400 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Article -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work